Literature DB >> 22193673

Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study.

Michael E Benros1, Philip R Nielsen, Merete Nordentoft, William W Eaton, Susanne O Dalton, Preben B Mortensen.   

Abstract

OBJECTIVE: Autoimmune diseases have been associated with an increased risk of schizophrenia. It has been suggested that brain-reactive autoantibodies are part of the mechanisms behind this association. Furthermore, an increased permeability of the blood-brain barrier has been observed during periods of infection and inflammation. The authors therefore investigated whether autoimmune diseases combined with exposures to severe infections may increase the risk of schizophrenia
METHOD: Nationwide population-based registers in Denmark were linked, and the data were analyzed in a cohort study using survival analysis. All analyses were adjusted for calendar year, age, and sex. Incidence rate ratios and accompanying 95% confidence intervals (CIs) as measures of relative risk were used.
RESULTS: A prior autoimmune disease increased the risk of schizophrenia by 29% (incidence rate ratio=1.29; 95% CI=1.18-1.41). Any history of hospitalization with infection increased the risk of schizophrenia by 60% (incidence rate ratio=1.60; 95% CI=1.56-1.64). When the two risk factors were combined, the risk of schizophrenia was increased even further (incidence rate ratio=2.25; 95% CI=2.04-2.46). The risk of schizophrenia was increased in a dose-response relationship, where three or more infections and an autoimmune disease were associated with an incidence rate ratio of 3.40 (95% CI=2.91-3.94). The results remained significant after adjusting for substance use disorders and family history of psychiatric disorders. Hospital contact with infection occurred in nearly 24% of individuals prior to a schizophrenia diagnosis.
CONCLUSIONS: Autoimmune disease and the number of infections requiring hospitalization are risk factors for schizophrenia. The increased risk is compatible with an immunological hypothesis in subgroups of schizophrenia patients.

Entities:  

Mesh:

Year:  2011        PMID: 22193673     DOI: 10.1176/appi.ajp.2011.11030516

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  178 in total

1.  A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents.

Authors:  Ole Köhler-Forsberg; Liselotte Petersen; Christiane Gasse; Preben B Mortensen; Soren Dalsgaard; Robert H Yolken; Ole Mors; Michael E Benros
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

Review 2.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

3.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 4.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 5.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.

Authors:  Vishwajit L Nimgaonkar; Faith Dickerson; Jennie G Pouget; Kodavali Chowdari; Colm O'Dushlaine; Joel Wood; Lambertus Klei; Bernie Devlin; Robert Yolken
Journal:  Psychiatry Res       Date:  2017-12-21       Impact factor: 3.222

7.  Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals.

Authors:  Holger J Sørensen; Philip R Nielsen; Michael E Benros; Carsten B Pedersen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2014-07-25       Impact factor: 9.306

8.  Morbidity and Mortality in the Children and Young Adult Offspring of Parents With Schizophrenia or Affective Disorders-A Nationwide Register-Based Cohort Study in 2 Million Individuals.

Authors:  Anne Ranning; Michael E Benros; Anne A E Thorup; Kirstine Agnete Davidsen; Carsten Hjorthøj; Merete Nordentoft; Thomas Munk Laursen; Holger Sørensen
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 9.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

10.  The link between schizophrenia and hypothyroidism: a population-based study.

Authors:  Kassem Sharif; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Arnon D Cohen; Yehuda Shoenfeld; Howard Amital
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.